{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:15:45Z","timestamp":1788236145030,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T00:00:00Z","timestamp":1146614400000},"content-version":"vor","delay-in-days":914,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> This multicenter prospective, randomized, double\u2010blind placebo\u2010controlled trial was designed to evaluate the effectiveness of polyenylphosphatidylcholine against the progression of liver fibrosis toward cirrhosis in alcoholics. Seven hundred eighty\u2010nine alcoholics with an average intake of 16 drinks per day were enrolled. To control excessive drinking, patients were referred to a standard 12\u2010step\u2013based alcoholism treatment program, but most patients refused to attend. Accordingly, study follow\u2010up procedures incorporated the essential features of the brief\u2010intervention approach. An overall substantial and sustained reduction in drinking was observed. Hepatic histological and other findings are described in a companion article.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Patients were randomized to receive daily three tablets of either polyenylphosphatidylcholine or placebo. Monthly follow\u2010up visits included an extensive session with a medical nurse along with brief visits with a study physician (hepatologist or gastroenterologist). A detailed physical examination occurred every 6 months. In addition, telephone consultations with the nurse were readily available. All patients had a liver biopsy before entry; a repeat biopsy was scheduled at 24 and 48 months.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> There was a striking decrease in average daily alcohol intake to approximately 2.5 drinks per day. This was sustained over the course of the trial, lasting from 2 to 6 years. The effect was similar both in early dropouts and long\u2010term patients, i.e., those with a 24\u2010month biopsy or beyond.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> In a treatment trial of alcoholic liver fibrosis, a striking reduction in alcohol consumption from 16 to 2.5 daily drinks was achieved with a brief\u2010intervention approach, which consisted of a relative economy of therapeutic efforts that relied mainly on treatment sessions with a medical nurse accompanied by shorter reinforcing visits with a physician. This approach deserves generalization to address the heavy drinking problems commonly encountered in primary care and medical specialty practices.<\/jats:p>","DOI":"10.1097\/01.alc.0000093744.12232.34","type":"journal-article","created":{"date-parts":[[2003,11,13]],"date-time":"2003-11-13T09:03:02Z","timestamp":1068714182000},"page":"1757-1764","source":"Crossref","is-referenced-by-count":58,"title":["I. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease: Effects on Drinking Behavior by Nurse\/Physician Teams"],"prefix":"10.1111","volume":"27","author":[{"given":"Charles S.","family":"Lieber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Groszmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenzo","family":"Paronetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Veterans Affairs Cooperative Study 391 Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,3]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"665","article-title":"NIDA\u2013NIAAA workshop: efficacy of therapies in drug and alcohol addiction\u2014strategies for treatment of alcohol problems","volume":"31","author":"Allen JP","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02658.x"},{"key":"e_1_2_1_4_1","volume-title":"Project on Identification and Management of Alcohol\u2010Related Problems","author":"Babor TF","year":"1992"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1993.tb00820.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196205000-00001"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00227-1"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540370029032"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02429.x"},{"key":"e_1_2_1_10_1","first-page":"69","article-title":"Alcoholism treatment in the United States: an overview","volume":"23","author":"Fuller RK","year":"1999","journal-title":"Alcohol Res Health"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.5.560"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1996.tb01147.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(99)00042-7"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(94)95023-7"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000093743.03049.80"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4679(199505)51:3<422::AID-JCLP2270510317>3.0.CO;2-B"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(96)00042-1"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595239400185211"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2001.62.211"},{"key":"e_1_2_1_20_1","volume-title":"Are Women More Vulnerable to Alcohol's Effect (Alcohol Alert No. 46)","author":"National Institute on Alcohol Abuse and Alcoholism","year":"1999"},{"key":"e_1_2_1_21_1","volume-title":"New Advances in Alcoholism Treatment (Alcohol Alert No. 49)","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2000"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1997.58.7"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595239100185371"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/37.12.2029"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90349-2"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1985.03360050065027"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1097%2F01.ALC.0000093744.12232.34","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.ALC.0000093744.12232.34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T19:18:17Z","timestamp":1700162297000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/01.ALC.0000093744.12232.34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1097\/01.ALC.0000093744.12232.34"],"URL":"https:\/\/doi.org\/10.1097\/01.alc.0000093744.12232.34","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}